SAb Biotherapeutics logo
  • About Us
    • Company Profile
    • Senior Management
    • Board of Directors
    • Clinical Advisory Board
  • Our Pipeline
  • Our Science
  • For Patients
  • Investors & Media
    • Overview
    • News & Press Releases
    • Presentations
    • Publications
    • Events
    • SEC Filings
    • Stock Quote & Chart
    • Senior Management
    • Board of Directors
    • Board Committees
    • Corporate Governance
    • Clinical Advisory Board
    • Analyst Coverage
    • RSS Feeds
    • Contact Us
  • Careers
  • Contact Us
  • About Us
    • Company Profile
    • Senior Management
    • Board of Directors
    • Clinical Advisory Board
  • Our Pipeline
  • Our Science
  • For Patients
  • Investors & Media
    • Overview
    • News & Press Releases
    • Presentations
    • Publications
    • Events
    • SEC Filings
    • Stock Quote & Chart
    • Senior Management
    • Board of Directors
    • Board Committees
    • Corporate Governance
    • Clinical Advisory Board
    • Analyst Coverage
    • RSS Feeds
    • Contact Us
  • Careers
  • Contact Us
Home > News
All | News | Press Release | Events
Jodi’s Journal: The Little Biotech Company That Could Beat COVID-19

Jodi’s Journal: The Little Biotech Company That Could Beat COVID-19

April 26, 2020
Behind SAB’s Rapid Response To COVID-19

Behind SAB’s Rapid Response To COVID-19

April 24, 2020
SAB Biotherapeutics Advances Therapeutic For COVID-19 In Partnership With Department Of Defense And BARDA

SAB Biotherapeutics Advances Therapeutic For COVID-19 In Partnership With Department Of Defense And BARDA

April 16, 2020
HHS Facilitates Development Of Immunotherapies For COVID-19 Patients

HHS Facilitates Development Of Immunotherapies For COVID-19 Patients

April 13, 2020
CSL Behring And SAB Biotherapeutics Join Forces To Deliver New Potential COVID-19 Therapeutic

CSL Behring And SAB Biotherapeutics Join Forces To Deliver New Potential COVID-19 Therapeutic

April 8, 2020
BARDA, Department Of Defense, And SAb Biotherapeutics To Partner To Develop A Novel COVID-19 Therapeutic

BARDA, Department Of Defense, And SAb Biotherapeutics To Partner To Develop A Novel COVID-19 Therapeutic

April 2, 2020
SAB Biotherapeutics Awarded $27M Contract  to Develop Novel Rapid Response Capability for U.S. Department of Defense

SAB Biotherapeutics Awarded $27M Contract to Develop Novel Rapid Response Capability for U.S. Department of Defense

March 31, 2020
SAB Biotherapeutics Delays Development At USD Discovery District

SAB Biotherapeutics Delays Development At USD Discovery District

March 13, 2020
Sioux Falls Biotech Firm Rushing To Develop Coronavirus Treatment

Sioux Falls Biotech Firm Rushing To Develop Coronavirus Treatment

March 12, 2020
Personal Impact, Global Influence, Right Here In South Dakota

Personal Impact, Global Influence, Right Here In South Dakota

February 18, 2020
SAB Biotherapeutics Announces Research Collaboration With CSL Behring

SAB Biotherapeutics Announces Research Collaboration With CSL Behring

January 7, 2020
South Dakota Leads The Future Of Fighting Disease

South Dakota Leads The Future Of Fighting Disease

December 13, 2019
Previous Next
SAb Biotherapeutics logo
  • ©2025 SAb Biotherapeutics, Inc.
  • All Rights Reserved
  • Terms & Conditions
  • Privacy Policy
  • Conflict of Interest Policy
  • Contact Us